Quris
Boston, US · 4 known investors
Quris develops a machine-learning platform for drug development, applying AI, engineering, and biology to predict how drugs will perform. The company works in the pharmaceutical and biotech space to improve how new drugs are tested and developed.
AI & Machine LearningBiotechHealthtech
Founders & leadership
IB
Isaac BentwichFounder & CEO
YH
Yossi HaranCo-Founder & CTO
Investors · 4
Competitors · 6
by search overlapQuralis8 shared keywordsQurAlis develops precision therapies for amyotrophic lateral sclerosis (ALS) and related neurodegenerative diseases by targeting specific disease-causing genetic drivers and molecular mechanisms. The company was founded by neuroscientists from Harvard to translate emerging discoveries about disease pathways into treatment breakthroughs for ALS patients.
Pulse26 shared keywordsPulse 2.0 is a business news publication covering company profiles, big tech, startups, and M&A deal flow. Based in Ann Arbor, Michigan, it produces articles on business, technology, venture capital, and consumer devices.
Qureator5 shared keywordsQureator develops non-animal testing methods for drug development, notably achieving an FDA IND approval without animal proof-of-concept data in collaboration with SillaJen. The company works in preclinical biotech, providing alternatives to animal testing for pharmaceutical partners.
Recursion (NASDAQ: RXRX)4 shared keywordsRecursion applies computational and data-driven approaches to biological science, aiming to accelerate drug discovery and develop new treatments. The company combines life scientists and software engineers to solve problems at the intersection of biology and technology.
Accuristech4 shared keywordsAccuris operates an Engineering Intelligence platform that connects global standards and electronic component data with AI and analytics to help engineers find and apply standards, assess supply chain risk, and source alternatives. It serves engineering organizations in industries such as aerospace, electronics, and energy.
Curi Bio4 shared keywordsCuri Bio provides a preclinical drug development platform combining 3D human tissue models of disease (cardiac and skeletal muscle), biosystems for functional analysis, and AI/ML-based insights to assess drug safety, efficacy, and potency. It serves pharmaceutical and biotech R&D teams working on drug discovery.
Companies competing with Quris for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Quris do?
- Quris develops a machine-learning platform for drug development, applying AI, engineering, and biology to predict how drugs will perform. The company works in the pharmaceutical and biotech space to improve how new drugs are tested and developed.
- Who are Quris's investors?
- Quris's investors include Fusion VC, SoftBank Vision Fund, Vox Capital, Welltech Ventures.
- Where is Quris headquartered?
- Quris is headquartered in Boston, US.